![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » BMP-7 PROMOTES REGENERATION OF INJURED KIDNEYS IN PRECLINICAL MODEL OF RENAL DISEASE
BMP-7 PROMOTES REGENERATION OF INJURED KIDNEYS IN PRECLINICAL MODEL OF RENAL DISEASE
Curis has announced that a recent online issue of the Journal of Biological Chemistry contains a report demonstrating that treatment with BMP-7, a signaling protein that was discovered by scientists from Curis, results in repair of kidney injury in a preclinical model of acute kidney disease.
There are currently no adequate therapies to promote repair of injured or diseased kidneys, according to the company. BMP-7 is a regulatory compound that controls a signaling pathway used by the body to maintain the normal health of the kidney and other tissues.
Previous BMP-7 studies have demonstrated its potential therapeutic utility in several different preclinical models of acute and chronic kidney disease, including a possible hormone replacement therapy to treat kidney-associated disorders such as metabolic bone disease and vascular calcification disease.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
11Jul
-
18Jul
-
21Oct